NSL

NSL Biotech is an India-based pharmaceutical and nutraceutical company established in 2017 that markets wellness and pain-relief formulations for distributor, wholesale, and procurement channels. The company focuses on science-driven combination products addressing bone strength, nerve function, immunity, energy, recovery, inflammation, and pain relief. Its portfolio includes branded softgel capsules, tablets, and injections such as Ostirol, VT-Good, Melatryp-D, Itoxib-P, Helifast, VILAGOOD-M, and BURTIN-24. Rather than highlighting proprietary drug discovery, NSL Biotech presents itself as a commercial-stage formulation supplier working with certified manufacturing partners to deliver compliant, quality-controlled products. The business appears oriented toward B2B healthcare distribution and supply-chain reliability across multiple regions in India.